AAA

ONCODESIGN PRECISION MEDICINE

No trades
See on Supercharts
Market capitalization
‪27.29 M‬EUR
−0.485EUR
‪−8.10 M‬EUR
‪1.10 M‬EUR
Beta (1Y)
−1.04

About ONCODESIGN PRECISION MEDICINE

CEO
Philippe Genne
Headquarters
Dijon
Employees (FY)
23
Founded
2020
ISIN
FR001400CM63
FIGI
BBG019VR0TK9
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. It has built a unique precision medicine platform dedicated to cancerous diseases and other diseases without therapeutic solution. Its innovative platform for the selection of new therapeutic targets has been developed on the basis of patient data and through a novel approach using Artificial Intelligence. The company was founded on December 15, 2020 and is headquartered in Dijon, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALOPM is 1.500 EUR — it has decreased by 1.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ONCODESIGN PRECISION MEDICINE stocks are traded under the ticker ALOPM.
ALOPM stock is 2.01% volatile and has beta coefficient of −1.04. Check out the list of the most volatile stocks — is ONCODESIGN PRECISION MEDICINE there?
Yes, you can track ONCODESIGN PRECISION MEDICINE financials in yearly and quarterly reports right on TradingView.
ALOPM stock has risen by 1.01% compared to the previous week, the month change is a 1.01% rise, over the last year ONCODESIGN PRECISION MEDICINE has showed a 40.19% increase.
ALOPM net income for the last quarter is ‪−4.16 M‬ EUR, while the quarter before that showed ‪−3.94 M‬ EUR of net income which accounts for −5.35% change. Track more ONCODESIGN PRECISION MEDICINE financial stats to get the full picture.
No, ALOPM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALOPM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCODESIGN PRECISION MEDICINE stock right from TradingView charts — choose your broker and connect to your account.
ALOPM reached its all-time high on Nov 8, 2022 with the price of 2.500 EUR, and its all-time low was 0.620 EUR and was reached on Oct 13, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 23.00 employees. See our rating of the largest employees — is ONCODESIGN PRECISION MEDICINE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCODESIGN PRECISION MEDICINE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCODESIGN PRECISION MEDICINE stock shows the sell signal. See more of ONCODESIGN PRECISION MEDICINE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ONCODESIGN PRECISION MEDICINE future price: according to them, ALOPM price has a max estimate of 2.66 EUR and a min estimate of 1.90 EUR. Read a more detailed ONCODESIGN PRECISION MEDICINE forecast: see what analysts think of ONCODESIGN PRECISION MEDICINE and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONCODESIGN PRECISION MEDICINE EBITDA is ‪−13.59 M‬ EUR, and current EBITDA margin is −881.82%. See more stats in ONCODESIGN PRECISION MEDICINE financial statements.